surpass 6 tirzepatide Effects of versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial Cardiovascular outcomes of semaglutide and

Retatrutide may be the more exciting name in todays weight-loss conversation, but tirzepatide remains the more practical option for patients who are looking for a treatment they can realistically discuss and begin now under proper medical supervision

If you stop treatment When you discontinue a GLP-1 medication, whether through stopping tirzepatide or stopping semaglutide , appetite and food intake typically increase

Our professionals are here to guide you through your weight loss journey, ensuring that your treatment is personalized to meet your unique needs

Semaglutide trials (STEP program) showed 1517% mean weight loss at highest doses

Its especially problematic for people in between the clinical diagnoses of overweight and obesity. Heres why using GLP-1s to lose 10 to 30 pounds has benefits beyond a smaller waistline